FDA PMA Approved 🇺🇸 United States

Pulmonary Valve Prosthesis Percutaneously Delivered

PMA: P200015 · Supplement: S005 · Decision Feb 17, 2021
Classifications
1
FEI Numbers
14
Registration Numbers
14

Basic Information

Device Name
Pulmonary Valve Prosthesis Percutaneously Delivered
Trade Name
SAPIEN 3 Transcatheter Heart Valve System
PMA Number
P200015
Supplement Number
S005
Product Code
NPV
Generic Name
Pulmonary valve prosthesis percutaneously delivered
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
February 17, 2021
Date Received
November 20, 2020
Supplement Type
Real-Time Process
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N

Advisory Committee Statement

Approval for the shelf life extension from 2 to 3 years.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NPV Pulmonary Valve Prosthesis Percutaneously Delivered